FDA Inspection
HCSC-Blood CenterHCSC-Blood Center – FDA Inspection, Jul 20, 2026
Record Details
This FDA Inspection record concerns HCSC-Blood Center, with an inspection on July 20, 2026, issued by the Philadelphia District Office, covering biologics.
View Company Profile
ID · d954c963-c909-4369-907b-a210664413ca
Inspection Facts
- Inspection number
- 1327046
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
- 21 CFR 606.160(b)Required records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of HCSC-Blood Center
7| Date | Classification | Office | Project area |
|---|---|---|---|
| June 16, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 21, 2020 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 15, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 1, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 12, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for HCSC-Blood Center
- FDA Inspection 1209789 - 2023-06-16
- FDA Inspection 1121127 - 2020-02-21
- FDA Inspection 1046306 - 2018-03-15
- FDA Inspection 963579 - 2016-03-01
- FDA Inspection 865598 - 2014-02-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.